Syndrome  >>  Decadron (dexamethasone)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Decadron (dexamethasone) / Merck (MSD)
NCT01692197: E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes

Completed
2
43
US
E7070, Idarubicin, Idamycin, Cytarabine, ARA-C, Cytosar, DepoCyt, Cytosine Arabinosine Hydrochloride, Dexamethasone, Decadron
M.D. Anderson Cancer Center, Eisai Inc.
Leukemia
06/17
06/17

Download Options